Aptus Capital Advisors, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1664193
FAIRHOPE, AL
Position in REGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$735,777
-$240,839 QoQ
Shares Held
1,180
-6.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#716
of 1,322 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 62%
Shared 0%
None 38%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Aptus Capital Advisors, LLC holds $18,389,150 across 17 Biotechnology names. REGN ranks #5 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13,787 | $6,848,416 | |
| 2 | OCUL |
Ocular Therapeutix, Inc
|
638,691 | $6,271,945 | |
| 3 | RPRX |
Royalty Pharma plc
|
24,206 | $1,357,230 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,389 | $1,020,190 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,180 | $735,777 | |
| 6 | MIST |
Milestone Pharmaceuticals Inc.
|
339,450 | $454,863 | |
| 7 | INCY |
Incyte Corp
|
2,549 | $288,954 | |
| 8 | EXEL |
Exelixis, Inc.
|
5,118 | $278,470 |
All Filings in REGN
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $735,777 | 1,180 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $976,616 | 1,264 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,283,619 | 1,663 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $844,529 | 1,502 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $794,325 | 1,513 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,005,888 | 1,586 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,139,015 | 1,599 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,023,907 | 974 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $990,070 | 942 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $869,128 | 903 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $684,187 | 779 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $661,659 | 804 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $354,958 | 494 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $373,038 | 454 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $261,900 | 363 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $346,501 | 503 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $299,702 | 507 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $404,385 | 579 | Shares | Sole | 2022-05-04 | |
| No filing history on record for this holder in this stock. | ||||||